Mitochondrial Complex I Deficiency Nuclear Type 10 C4748768
A rare genetic disorder that impairs mitochondria's energy production capacity. It can affect multiple organ systems and varies in severity. Management involves supportive therapies and monitoring affected organs.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Sudden weakness
Fatigue or weight changes
(metabolic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Growth retardation
(developmental)Renal tubular dysfunction
(renal)Hepatic dysfunction
(hepatic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Coenzyme Q10 (Ubiquinone) Supplementation
Coenzyme Q10 is an essential electron carrier in the mitochondrial electron transport chain. Supplementation may help bypass complex I defects and improve ATP production. Response varies by patient and underlying genetic mutation.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Ketogenic Diet Therapy
A high-fat, low-carbohydrate diet that provides alternative energy substrates through ketone body metabolism, potentially bypassing impaired complex I function. Requires careful medical supervision and monitoring.
Additional treatment options
L-Carnitine Supplementation
Carnitine facilitates fatty acid transport into mitochondria and helps remove toxic metabolites. May support mitochondrial function and reduce metabolic stress in patients with complex I deficiency.
medicationMultisystem Monitoring Program
Regular surveillance of cardiac, neurological, hepatic, and renal function through echocardiography, EEG, and laboratory testing to detect and manage complications early.
monitoringEnergy Conservation Strategies
Implementation of pacing techniques and activity modification to prevent metabolic crises. Includes scheduled rest periods, avoidance of overexertion, and stress management.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Mitochondrial Complex I Deficiency Nuclear Type 10 C4748768?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Mitochondrial Complex I Deficiency Nuclear Type 10 C4748768. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy